MOBY® keeps life moving.
Human connection is our most essential superpower. MOBY is created to secure freedom and human contact, even in the most precarious of medical situations. Because together, we get better.
Clinicians' first choice.
Enhancing quality of life
Human connection is vital for patient recovery. By enabling safe, close, and clear interaction, MOBY fosters a supportive healing environment—even under isolation protocols.
Improved patient safety
Designed to prevent cross-contamination and minimize risks during transport, MOBY prioritizes patient well-being and peace of mind.
More effective routines
Relieves pressure on patients and professionals by reducing impossible choices between human connection and safety.
Protecting what matters most.
MOBY is a mobile protective pod. It surrounds the patient with a filtered, pressure-controlled environment that travels with them, so they can leave the room. Positive pressure for the immunocompromised patient, negative pressure for the infectious one.
Developed with the clinicians who use it.
“We want MOBY to be available wherever a child needs a transplant. For our patients, it is a real and lasting improvement in their care.”
“I hope that the use of MOBY for immunocompromised children with cancer will be an important step towards breaking the burdening isolation of our patients.”
“As Sphaira's clinical partner, we are delighted to help shape the development of MOBY. With it, visits to our facilities become possible regardless of the infection situation. At the same time, we expect MOBY to fundamentally improve the daily lives of patients in protective isolation. I believe that human contact between patients and their families supports healing and leads to better outcomes. That is what we expect from MOBY, too.”
CE marked. Deployed. Under study.
Charité – Universitätsmedizin Berlin
Prospective cohort study at Charité Berlin on quality of life in pediatric patients with severe immunosuppression.
Investigator-initiated multicenter study in planning. Pilot study in the United States in drafting.
CE-marked medical device under EU MDR 2017/745.
In active dialogue with the U.S. FDA. Not available for sale in the United States.
Built for the strictest isolation protocols.
Wherever isolation prohibits movement or seeing loved ones, MOBY belongs.
Stem cell transplantation
Leave the room without leaving protection.
Solid organ transplantation
Protected mobility during induction immunosuppression.
Severe burns
Protected transport and protected visits.
Pediatric oncology
Time outside the room for children in prolonged neutropenia.
Acute myeloid leukemia
Induction and consolidation without weeks behind a door.
Palliative care
Contact and movement when they matter most.
Source isolation
The hospital stays protected while the patient moves.
The best way through is together.
Whether you run a transplant unit, lead hospital hygiene, or bring medical technology to a new market, we would like to talk.